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Abstract
Comparative metabolic modelling is emerging as a novel field, supported by the development of reliable and standardized
approaches for constructing genome-scale metabolic models in high throughput. New software solutions are needed to
allow efficient comparative analysis of multiple models in the context of multiple cellular objectives. Here, we present the
user-friendly software framework Multi-Metabolic Evaluator (MultiMetEval), built upon SurreyFBA, which allows the user to
compose collections of metabolic models that together can be subjected to flux balance analysis. Additionally, MultiMetEval
implements functionalities for multi-objective analysis by calculating the Pareto front between two cellular objectives. Using
a previously generated dataset of 38 actinobacterial genome-scale metabolic models, we show how these approaches can
lead to exciting novel insights. Firstly, after incorporating several pathways for the biosynthesis of natural products into
each of these models, comparative flux balance analysis predicted that species like Streptomyces that harbour the highest
diversity of secondary metabolite biosynthetic gene clusters in their genomes do not necessarily have the metabolic
network topology most suitable for compound overproduction. Secondly, multi-objective analysis of biomass production
and natural product biosynthesis in these actinobacteria shows that the well-studied occurrence of discrete metabolic
switches during the change of cellular objectives is inherent to their metabolic network architecture. Comparative and
multi-objective modelling can lead to insights that could not be obtained by normal flux balance analyses. MultiMetEval
provides a powerful platform that makes these analyses straightforward for biologists. Sources and binaries of MultiMetEval
are freely available from https://github.com/PiotrZakrzewski/MetEval/downloads.
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Introduction
Living cells owe their existence to complex metabolic networks,
in which large numbers of chemical conversions occur to allow the
cells to harvest energy, sustain themselves and reproduce. In the
past decades, methodologies have been developed to systematically
describe and quantitatively analyse (parts of) the metabolic
network of a cell in computational models [1,2]. Such reconstruc-
tions have already been of great use to develop a better
understanding of the metabolic architecture and dynamics of
various organisms [3,4].
Genome-scale constraint-based metabolic models are recon-
structions of metabolism that comprise the stoichiometries of all
reactions predicted from whole genome sequences based on the
presence of enzyme-coding genes. Accordingly, they can be used
to model the steady-state behaviour of the metabolism of a whole
organism [5,6]. Well-accepted procedures on how to generate
genome-scale constraint-based models are available, based on
Enzyme Classification annotations and generic gap-filling proce-
dures [7].
The resulting metabolic models can be used to perform several
kinds of analyses [8,9], the most popular one being flux balance
analysis (FBA) [10]. In this method, the fluxes of metabolites
through the network are calculated based on the stoichiometry of
each reaction and an objective function that specifies for which
goal (e.g. maximization of biomass production from a given input
or minimization of nutrient uptake) the fluxes are optimized.
Recently, high-throughput methods have been developed to
generate and gap-fill metabolic models for multiple species in
a rapid and standardized way [11], based on genome annotations
obtained with a uniform method. Even though the resulting
models still need to be compared with experimental data to
achieve optimal quality [12] and the gap-filling implemented by
SEED is not always optimal [13,14], automatically generated
models that have undergone a limited amount of manual curation
are already useful for obtaining a rough assessment of the
metabolic capabilities of cellular systems.
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The standardization offered by automation opens up the road
for comparative modelling, as little model reconciliation is needed,
in contrast to what is usually the case for manually reconstructed
models [15]. Comparative analysis of genome-scale metabolic
models is an intriguing new field with diverse potential applica-
tions [16,17]. For example, it can be used to detect evolutionary
differences between metabolic networks of related species and
predict their relative adaptive ecological value [18]. It can also be
used to assess the suitability of a range of species for a particular
biotechnological application (e.g., biofuel or drug production)
based on the topologies of their metabolic networks, which could
then inform the choice of industrial production hosts [19].
As well as studying multiple models at the same time, it can also
be very revealing to optimize models for multiple objectives
simultaneously [20,21]. Many different ‘natural’ objective func-
tions have been proposed, such as maximization of biomass,
secondary metabolite production or ATP production, minimiza-
tion of total flux, minimization of redox potential, and minimi-
zation of nutrient uptake [22]. For most of these, there are reasons
to believe that the cellular flux distribution can be expected to
have evolved in a way that optimizes the objective, at least under
specific conditions. It can even be argued that evolution has driven
biological systems toward an optimal compromise between all of
these, sometimes conflicting, objectives. Other relevant objective
functions that one would like to consider are those that correspond
to the aims of bioengineering instead of evolution, such as the
maximization of the production of a specific metabolite. Un-
fortunately, as implementing different objective functions is
relatively difficult in most existing analysis platforms, many
published studies have been restricted to exploring a single
objective function, usually maximization of biomass production
(although interesting studies have been performed that explore
different objective functions, e.g. [23], some of which have been
made available through the COBRA toolbox [24]).
A pair of objective functions (such as a biomass objective
function and the objective function of production of a specific
compound) can be balanced to find the so-called Pareto front [25]
between the two objectives. The Pareto front comprises the set of
‘‘Pareto-optimal’’ solutions, for which one objective can only be
improved at the expense of the other objective. Bacterial
metabolism has recently been shown to operate close to such
Pareto fronts [26]. An analysis of such a front enables one to
predict the interactions between different metabolic processes and
priorities within the cell. For example, one can identify the extent
to which two objectives compete for the use of the same enzymatic
pathways. Moreover, one can use the results to predict the balance
between the objectives that is optimal for sustaining biomass levels
while producing as much of a certain valuable metabolite as
possible.
Here, we describe a new software package, Multi-Metabolic
Evaluator (MultiMetEval), a simple framework that provides an
efficient and user-friendly interface for the comparative study of
multiple models and the use of multiple objective functions. The
software has been conveniently linked up to the SurreyFBA
package for metabolic modelling [27], allowing for easy interaction
with general modelling algorithms. In order to make the tool
widely useful, it includes a new global SBML Level 2 parser that
enables input of models from popular modelling platforms,
including SEED [11,28], KGML [29] and COBRA [30],
overcoming previous compatibility issues between different SBML
flavours that severely impaired comparative analyses. Moreover,
all functionalities are organized in a graphical user-interface that
allows the user to quickly generate publication-quality plots from
the results and export the results for downstream analyses in other
software packages.
In a case study, we show how the principles of comparative
modelling can be applied to a concrete biological problem with
our software, in a comparative study of the metabolic networks of
38 actinobacteria. Based on the 38 genome-scale models, we
predict the suitability of different bacterial strains for the
heterologous production of a range of different secondary
metabolites and use multi-objective analysis to study the dynamic
balance between the biomass objective and the compound
production objective. We find that the maximally attainable fluxes
to a natural product vary greatly between species as well as
between the chemical classes of compounds. Moreover, we
observe discrete switch-like behaviour in the models when the
priority of the compound production objective function is
gradually increased compared to the biomass objective function;
this provides a possible systems-level explanation for the metabolic
switches observed in the onset of secondary metabolism in such
organisms [31].
Design and Implementation
The MultiMetEval comparative analysis framework was written
in Java 6 Standard Edition with an interface handled by the Swing
framework and integrated plot generation handled by the
JFreeChart library. It is functional in both Windows and Linux
operating systems. The program was built upon the SurreyFBA
framework [27], which is used as an engine for the basic FBA
calculations. Additionally, in order to read input models from
a large range of sources (e.g. SEED [11,28] and COBRA [30]),
a Python-based universal SBML parser was generated to convert
input SBML files into a valid SurreyFBA input format. Combined
with the parser and the SurreyFBA engine, MultiMetEval allows
for high-throughput comparative and multi-objective analysis of
metabolic models that share the same syntax.
Parsing of Input SBML Files
Incompatibility of SBML models coming from different frame-
works has been a major drawback for comparative studies [15].
SBML Level 2 itself is a general-purpose language for systems
biology, and can be used for storing a great number of data types.
There is, however, still no universally adopted definition of FBA-
specific parameters within the SBML namespace. Therefore,
gene-protein-reaction association rules and reaction capacity
bounds have to be defined using annotations and general
parameters. This leads to many different format varieties of
SBML, in which the data relevant for FBA are stored in different
ways.
Existing FBA frameworks make use of their own parsers
enforcing usage of their own SBML format variety. In order to
make SBML files from different frameworks cross-compatible in
our tool, we generated a parser that can convert any major SBML
format variety into the SurreyFBA format. As we show in Table 1,
our parser adds a flexibility that has not been possible in the other
major FBA tools. In principle, our parser could easily be
implemented in other contexts as well.
Comparative Analysis
MultiMetEval provides a user-friendly facility to perform
comparative analysis of multiple metabolic models, by combining
batch runs of the single model analysis functionalities provided by
SurreyFBA with new features that allow for convenient multi-
model input and output.
The basic units analysed by the comparative analysis module
are ‘‘model collections’’, which are sets of models selected by the
Metabolic Modelling with MultiMetEval
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user for analysis and parsed into the same format by the universal
SBML parser.
A specific menu allowing user-friendly construction of such
collections is available via the File menu. To allow reuse of models
in different collections, the collections can be created as subsets of
a main model repository that holds all models that were imported
to the program. Models can easily be added to the main repository
and then moved to any collection in the same window.
For every model, the number of reactions, metabolites, orphan
reactions and orphan metabolites are detected and displayed in
MultiMetEval’s main overview table when a collection is opened.
FBA can be performed on the entire collection at once by clicking
a simple menu button, and results are output in a single
spreadsheet table (Figure 1).
Our framework also offers a growth medium editor, which
allows comparative analysis not only of different models, but also
in different growth conditions. In order to make sure that the
medium is compatible with the models, the medium description
format used in our framework operates only on the metabolites
present in a given collection and restricts the choice of medium
ingredients to those which were defined in any of its models as
external. The motivation for this is, of course, that these are the
only metabolites that can be consumed by at least one model.
Multi-objective Analysis by Pareto Front Calculation
MultiMetEval allows performing multi-objective analysis by
calculating the Pareto front [20,32] for maximization of two given
reactions. Compared to the weighted sum approach (which was
already implemented in SurreyFBA), Pareto front calculation is
more informative, as it avoids the arbitrary nature of weight
assignment.
In this analysis, MultiMetEval calculates the tradeoff between
two objectives. Often, the first objective will be the biomass
production reaction, but, in principle, MultiMetEval can calculate
a Pareto front for the optimization of any combination of two
fluxes of reactions that co-occur in the same model.
In the Pareto front calculation, first the maximal possible flux of
the first objective is calculated. This value will be used in the
following steps as a constraint that is iteratively decreased at each
step. So after calculating the maximal flux of objective one, the
program will carry out optimizations for the second objective n
times (were n represents the resolution), and with each simulation
step the constraint put on the reaction by the first objective will
decrease unless its value reaches zero.
The results of the multi-objective analysis are output to a results
table as well as in a visual plot (Figure 2).
In addition to the implementation of the Pareto trade-off
routine in the MultiMetEval framework described here, we also
implemented it in the SurreyFBA command-line interface as well
as in JyMet, the single-model analysis framework from SurreyFBA
[27], for additional flexibility.
Results and Discussion
Comparative and multi-objective metabolic modelling has
many exciting applications in systems and synthetic biology
[4,33,34]. To illustrate the power of these approaches, we applied
the MultiMetEval tools in an exemplary case study on the
production of secondary metabolites in actinobacteria. We show
how comparative FBA can be used to identify differences between
organisms in their theoretical production capacities for such
metabolites, as well as differences in the extent to which biomass
production competes with secondary metabolite biosynthesis.
Comparative FBA of Secondary Metabolite Biosynthesis
by 38 Actinobacteria
In our comparative FBA analysis, we constructed a model
collection in MultiMetEval from the 38 genome-scale metabolic
models of actinobacteria that were recently constructed and
curated by Alam et al. [17] (excluding the two Tropheryma models,
but including models for Bifidobacterium adolescentis ATCC 15703,
Bifidobacterium longum NCC2705 and Kineococcus radiotolerans
SRS30216). We then reconstructed biosynthetic pathways for 15
secondary metabolites of different classes that were present as
annotated pathways in the KEGG database. These included
polyketides (erythromycin, tylosin, aureomycin, tetracycline),
aminoglycosides (butirosin, neomycin, streptomycin), aminocou-
marins (clorobiocin, coumermycin, novobiocin), nonribosomal
peptides (enterobactin, pyochelin, cephalosporin, penicillin) and
a beta-lactam (clavulanic acid). Such types of compounds are
highly relevant biotechnologically, because they often have
antimicrobial or anti-cancer activities [35]. Their biosynthetic
pathways can be (re-)engineered with synthetic biology approaches
and expressed for purposes of drug discovery and industrial
production [36]. For each of the 15 metabolites, derivative models
were then made for all 38 actinobacteria, in which the biosynthetic
pathway for the metabolite was added to the genome-scale model.
For all 38 N 15=570 models, FBA was then performed using
MultiMetEval on a minimal medium with equal amounts of
glucose as the sole carbon source, ammonium as the sole nitrogen
source, and orthophosphate as the sole phosphorus source. The
cellular objective was maximization of the production of the
secondary metabolite. A limited number of (maximally seven)
reactions for glucose uptake and methionine biosynthesis, as well
as compound-specific reactions for precursor biosynthesis were
added to each model to enable it to produce the compound on the
minimal medium (see Table S1).
Figure 3 shows the resulting heat map representing the
theoretical maximal production rates of the 15 secondary
Table 1. Comparison of parsing capabilities of MultiMetEval with other FBA frameworks.
Framework SEED-generated SBML KGML-derived SBML COBRA-generated SBML
MultiMetEval + + +
COBRA – +/2 +
VANTED – + –
SurreyFBA 1.0 – +/2 +
Table showing SBML parsing abilities of the most popular FBA tools. Only the MultiMetEval parser is able to successfully process SBML models from SEED [11,28], KGML
[29] and COBRA [30].
doi:10.1371/journal.pone.0051511.t001
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metabolite classes in all 38 actinobacteria. The intensity of a colour
depicts the relative flux rate – the lighter the colour (closer to
white), the higher a given flux value is in comparison to others
from the same column.
As no regulatory and kinetic information is used in the
constraint-based models, one should note that the variation
observed between the species only represents the difference due
to differences in network topology given the medium composition
used. Still, it is intriguing that substantial differences in theoretical
production capacities are observed between the actinobacterial
species. As expected, we observe some correlation with general
topological properties of the metabolic networks such as the
numbers of reactions and metabolites: minimalistic genomes
generally tend to be less efficient predicted production hosts
(e.g., Bifidobacterium and Propionibacterium). However, these differ-
ences clearly do not account for all the variation observed. Among
the most interesting exceptions is the severely genome-minimized
Mycobacterium leprae, which still reaches surprisingly high predicted
fluxes. Members of the same class of secondary metabolite (which
also have similar precursors) are usually predicted to be most
efficiently produced in the same hosts. An exception is formed by
two nonribosomal peptides, cephalosporin and enterobactin, for
which fewer species are able to obtain the maximum observed flux
towards compound production than for two other nonribosomal
Figure 1. Workflow of comparative metabolic analysis in MultiMetEval.
doi:10.1371/journal.pone.0051511.g001
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peptides, pyochelin and penicillin. This is probably due to the
requirement of additional precursors, 2-oxoglutarate and 2,3-
dihydroxybenzoic acid, respectively, for these two molecules,
which are not required for penicillin and pyochelin.
When we investigated the presence of which reactions influence
fluxes most, by calculating the correlation between reaction
presence/absence and maximum fluxes for each compound (Table
S2), we could observe that in at least a number of cases this
corroborated current biochemical knowledge. For example,
clavulanic acid fluxes most strongly correlate with the presence
of a reaction (rxn00101) to convert urea into CO2 and NH3, which
corroborates the unusual presence of a microbial urea cycle in its
native host organism Streptomyces clavuligerus [37,38]. Also, the fluxes
towards several compounds (the macrolides, aminocoumarins and
pyochelin) correlated with the presence of a reaction (rxn00141)
converting S-adenosylhomocysteine to adenosine and homocys-
teine, which corroborates evidence for a positive effect of S-
adenosylmethionine regeneration on antibiotic biosynthesis [39].
Interestingly, the fact that the genome of a species has a lot of
secondary metabolite biosynthetic gene clusters does not neces-
sarily mean that its metabolic network is optimized for a higher
production of such metabolites compared to other species: high
metabolite diversity does not imply high metabolite production
titers. The fact that streptomycetes, such as Streptomyces coelicolor and
Streptomyces avermitilis, famous for their production of a wide variety
of clinically and biotechnologically important secondary metabo-
lites [40,41] and endowed with about 25–30 gene clusters per
genome, do not score particularly highly suggests that their
metabolic networks may not have been optimized for achieving
high production titers of such metabolites during their evolution.
This may partly explain why extensive metabolic engineering and
classical strain optimization have usually been essential to optimize
production strains for economically viable metabolite production,
often with tremendous improvements in titres [42–44].
On the other hand, models representing species from the
taxonomic branch of free-living mycobacteria (Mycobacterium
vanbaalenii, Mycobacterium sp. MCS, and Mycobacterium sp. JLS)
achieve the highest predicted production rates for secondary
metabolites in the simulations, although they have only about 15
secondary metabolite gene clusters per genome. The difference
with the pathogenic Mycobacterium species, such as M. tuberculosis,
M. bovis and M. leprae, may be explained by the further genome
minimization of the pathogenic species, which may have led to
a loss of flexibility in the metabolic networks and consequently an
increase in pathway competition.
Generally, comparative modelling as described here could lead
to a more systematic approach towards the identification of
suitable ‘‘universal hosts’’ for heterologous expression of gene
clusters [47–49]. Specifically, this preliminary analysis already
suggests that free-living mycobacteria might be an attractive
starting point for the generation of a minimal actinobacterial
genome for use in synthetic biology approaches [45,46], especially
as all three of them belong to the fast-growing mycobacteria.
As expected, similar patterns of theoretical maximal production
rates across organisms were observed for compounds with similar
chemical structures, such as the aminocoumarins novobiocin,
coumermycin and clorobiocin. Also notable is that the metabolic
networks of some organisms appear more fit for the production of
certain compounds than others. For example, Renibacterium
salmoninarum ATCC 32209 is predicted to be one of the best
producers of polyketides and one of the worse producers of
clavulanic acid. This suggests that the species differences observed
are not caused by the presence or absence of single enzymes, but
that different factors play a role for different compound types.
Some aspects that could play a role are 1) the presence or absence
of pathways directed towards the necessary precursors (metabolic
detours are probably energetically costly), 2) efficiency of ATP
generation from the used carbon source glucose, and 3) the ability
of models to re-utilize the (sometimes quite exotic) side products of
biosynthetic pathways to generate more precursors.
Of course, it should be kept in mind that this study used only
mildly curated automatically generated metabolic network models
to illustrate the main concepts of comparative flux balance
analysis, and a more careful manual curation will be needed before
committing substantial experimental resources to testing the
hypotheses suggested here. Additionally, more systematic analysis
of the specific differences between topologies associated with high
and low production capacities of the different compound types
may offer specific leads for metabolic engineering, by revealing
topological bottlenecks. Another interesting follow-up study would
Figure 2. Table and plot output from the Pareto front calculation routine. The first steps are identical to those in Figure 1, except that only
one organism is selected and two reactions are selected to calculate their trade-off.
doi:10.1371/journal.pone.0051511.g002
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consist of designing several additional media to study the dynamic
interactions between network topology and medium composition
or environmental niche.
Analysis of the Trade-off between Secondary Metabolite
Biosynthesis and Biomass Production
Biotechnological optimization of natural product biosynthesis
often suffers from pathway competition with fluxes leading to the
synthesis of biomass components [50,51]. In order to assess
competition between secondary metabolite biosynthesis and
biomass production for selected key species and metabolites, we
used multi-objective analysis to calculate Pareto fronts between the
biomass objective and the compound production objective.
In Figure 4, the y-axis on each plot represents the flux rate
through the final biosynthesis reaction in the pathway for
production of the given compound. The x-axis on each plot
represents the percentage of maximal biomass production flux
achieved. The region underneath the blue line represents the
space of feasible solutions.
The predictions suggest that the overlap between network
resources needed for biomass production and compound pro-
duction differs notably between species, even without taking into
account the organism-specific biomass compositions. It is likely
that this has to do with the rate with which the network topology
of a species enforces pathway competition between the two
objectives, and to which extent alternative pathways are available
for both processes.
The applied multi-objective analysis thus characterizes organ-
ism-specific relationships between biomass production and com-
pound biosynthesis. Methods such as OptKnock [52] can
subsequently enable metabolic engineers to reach a position close
to the identified Pareto front, by determining how the compound
Figure 3. Theoretical maximum fluxes of secondary metabolite production. The heat map shows relative maximal fluxes of the final
biosynthetic step in the metabolic pathways leading 15 different secondary metabolites, which were incorporated into the genome-scale metabolic
models of 41 actinobacteria. Flux balance analysis was performed on the minimal medium described by Alam et al. [17]. White indicates a high
relative flux level, red indicates a low relative flux level (as % of the maximally obtained value across all species, displayed at the top of the figure). In
the heatmap on the left, the number of model reactions and metabolites, the genome sizes and the number of secondary metabolite biosynthesis
gene clusters (predicted using antiSMASH [54]) are plotted.
doi:10.1371/journal.pone.0051511.g003
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production objective can be optimized given a certain biomass rate
by for example stoichiometrically forcing the strain to synthesize
a target compound as a by-product of growth.
In the simulations for pyochelin, biomass production at biomass
maintenance levels (the almost horizontal plateau at the beginning
of the curves) hardly competes with compound production. It
appears that in this case the production of biomass components
from the medium leaves several metabolic resources unused at the
point where the first nutrient limitation from the medium prevents
higher biomass production. We confirmed this by recalculating the
trade-off under several different medium conditions. Indeed, we
observed that pyochelin production and biomass production were
constrained by different nutrient limitations: orthophosphate and
NH3 were the limiting medium ingredients, respectively. When
medium influx bounds of these compounds were increased by
100% each, the horizontal plateau disappeared.
In that sense, there is a ‘‘free lunch’’ for compound production
as long as it is limited by a different nutrient than biomass
production is. Remarkably, this suggests that production titers of
industrial strains can sometimes be optimized without costs to the
biomass maintenance.
In most plots, a single transition point is observed, at which the
production titre starts to drop much more drastically when
biomass production is increased. This might signify that the
metabolic networks of these microbes have at least two distinguish-
able states in which a different nutrient is limiting for compound
production given the fixed biomass production flux at that point. A
‘‘metabolic switch’’ seems to operate at this point, at which the
regulation of metabolism probably needs to be drastically changed
to maintain optimal levels of both biomass and compound
production (i.e., to remain near the Pareto front). Of course,
switch-like behaviour would be expected given that FBA is based
on linear programming, and different linear constraints will be
limiting at different points in the graph. Nonetheless, the fact that
the switches corroborate observations from experimental micro-
biology, in which a carefully regulated switch has been observed at
the onset of secondary metabolite biosynthesis [31,53], suggests
that cells may employ regulatory mechanisms to remain very close
to such a theoretical polygon-shaped Pareto front [26].
Figure 4. Pareto front calculation between biomass production and secondary metabolite biosynthesis. Pareto fronts are given for four
species and three different natural products. To estimate secondary metabolite production, the flux rate through the final step in the biosynthetic
pathway of the corresponding compound was used as a proxy.
doi:10.1371/journal.pone.0051511.g004
Metabolic Modelling with MultiMetEval
PLOS ONE | www.plosone.org 7 December 2012 | Volume 7 | Issue 12 | e51511
Conclusions
Comparative metabolic modelling is a new field, and as with
any recent advance in biology, new software solutions are needed
to achieve its full potential. With MultiMetEval, we provide an
easy-to-use software framework to analyse large collections of
metabolic models in parallel and to perform multi-objective
analysis, coupled to the SurreyFBA framework. Although this is
just a starting point for further software development, the tool
already allowed us to study secondary metabolism in actinobac-
teria in novel ways. Most interestingly, comparative analysis of
their genome-scale models predicts that the organisms whose
genomes encode the largest numbers of biosynthetic gene clusters
do not necessarily have the metabolic network topology most
suited for industrial production of these compounds, suggesting an
interesting line of enquiry for future experimental work.
Additionally, results from multi-objective analysis suggest that
bacterial metabolic switches are not just enforced by regulation,
but are grounded in the very architecture of the metabolic system
in which they occur. We expect that further experimental analysis
will likely give exciting definitive insights into these phenomena.
Supporting Information
Table S1 Used methods for integration of KEGG path-
ways towards the biosynthesis of secondary metabo-
lites. To integrate the KEGG pathways for secondary metabolite
biosynthesis in all 38 actinobacterial models, compound-specific
Python scripts were written which used our in-house PyModelE-
ditor to edit the models in such a way that they would allow
simulation of compound biosynthesis. For the fifteen compounds
chosen, different modifications had to be made to the models, as
indicated in this table. The minimal medium used for flux balance
analysis (FBA) consisted of H2O (influx upper bound 10000), O2
(10000), glucose (10), NH3 (10), PO4
32 (10), SO4
22 (10), CO2 (10),
H+ (10), Cu2+ (10), Pb2+ (10), Zn2+ (10), Mn4+ (10), CrO4
22 (10),
Mg2+ (10), K+ (10), Co2+ (10), Ca2+ (10), Fe2+ (10), Fe3+ (10), Cl2
(10), Ni2+ (10), Na+ (10), Cd2+ (10). Also, low influx of octadecanoic
acid (0.001) was allowed, which was necessary to ‘start up’ some
essential biosynthesis reactions.
(DOCX)
Table S2 Correlation between reaction presence/ab-
sence and maximum fluxes. For each compound, this table
shows the squared correlation coefficient (r2) of the absence/
presence of reactions in a metabolic model and the maximum flux
obtained during flux balance analysis. The reaction name is the
name as it is given in the SEED database, and the reaction
formula corresponding to each reaction is given in the third
column.
(XLSX)
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